IRIDEX Corporation (IRIX)Healthcare | Medical Devices | Mountain View, United States | NasdaqCM
0.71 USD
-0.01
(-0.814%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.71 +0.00 (0.241%) ⇧ (Aug. 28, 2026, 7:05 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 4:19 a.m. EDT
The investment case here is defined by a stark disconnect between the company's deteriorating reality and the market's desperate hope for a turnaround. Fundamentally, the business is in freefall: revenue has contracted by 7.4% year-over-year, profitability is nonexistent with negative operating margins, and the balance sheet shows significant equity erosion with a negative book value. The multi-year price trajectory confirms this structural decline, having lost over 91% of its value since 2016, with the most recent annual performance also showing a drop. While the analyst consensus is a 'strong buy' with a target price nearly four times the current level, this appears to be a speculative bet on a potential product inflection rather than a reflection of current operational health. The options market mirrors this gamble, with traders loading up on deep out-of-the-money calls while ignoring downside protection. For a rational investor, the negative fundamentals and lack of cash generation outweigh the speculative upside potential. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.252749 |
| AutoARIMA | 0.260598 |
| AutoETS | 0.261371 |
| AutoTheta | 0.302238 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 38% |
| H-stat | 16.00 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.323 |
| Excess Kurtosis | -1.05 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 110.278 |
| Revenue per Share | 2.991 |
| Market Cap | 12,297,705 |
| Forward P/E | Infinity |
| Beta | 0.64 |
| Profit Margins | -6.88% |
| Website | https://www.iridex.com |
As of Aug. 22, 2026, 4:19 a.m. EDT: Speculators are overwhelmingly positioning for a massive rally, with open interest concentrated entirely in out-of-the-money calls at strikes of $2.50, $5.00, and $7.50. This 'lottery ticket' style positioning suggests a belief in a multi-bagger recovery, while put buyers are virtually absent, indicating a lack of hedging against further downside.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.47014928 |
| Address1 | 1,212 Terra Bella Avenue |
| All Time High | 18.5 |
| All Time Low | 0.36 |
| Ask | 0.923 |
| Ask Size | 2 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 156,570 |
| Average Daily Volume3 Month | 71,924 |
| Average Volume | 71,924 |
| Average Volume10Days | 156,570 |
| Beta | 0.64 |
| Bid | 0.4988 |
| Bid Size | 1 |
| Book Value | -0.135 |
| City | Mountain View |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.7065 |
| Current Ratio | 1.819 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 0.7199 |
| Day Low | 0.7001 |
| Debt To Equity | 110.278 |
| Display Name | IRIDEX |
| Earnings Call Timestamp End | 1,787,086,800 |
| Earnings Call Timestamp Start | 1,787,086,800 |
| Earnings Timestamp | 1,787,083,200 |
| Earnings Timestamp End | 1,794,945,600 |
| Earnings Timestamp Start | 1,794,945,600 |
| Ebitda | -2,604,000 |
| Ebitda Margins | -0.05049 |
| Enterprise To Ebitda | -6.814 |
| Enterprise To Revenue | 0.344 |
| Enterprise Value | 17,742,610 |
| Eps Current Year | -0.12 |
| Eps Forward | 0.0 |
| Eps Trailing Twelve Months | -0.2 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 650 940 4710 |
| Fifty Day Average | 0.954 |
| Fifty Day Average Change | -0.2475 |
| Fifty Day Average Change Percent | -0.25943395 |
| Fifty Two Week Change Percent | -47.014927 |
| Fifty Two Week High | 1.65 |
| Fifty Two Week High Change | -0.9435 |
| Fifty Two Week High Change Percent | -0.5718182 |
| Fifty Two Week Low | 0.7 |
| Fifty Two Week Low Change | 0.0065000057 |
| Fifty Two Week Low Change Percent | 0.009285723 |
| Fifty Two Week Range | 0.7 - 1.65 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 824,481,000,000 |
| Float Shares | 5,220,467 |
| Forward Eps | 0.0 |
| Forward P E | Infinity |
| Free Cashflow | 1,643,125 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 93 |
| Fullday Change | -0.00580001 |
| Fullday Change Percent | -0.814265 |
| Fullday Price | 0.7082 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.35924 |
| Gross Profits | 18,527,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.36735 |
| Held Percent Institutions | 0.19461 |
| Implied Shares Outstanding | 17,406,518 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ir Website | http://phx.corporate-ir.net/phoenix.zhtml?c=112360&p=irol-irhome |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,398,400 |
| Long Business Summary | IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat uncontrolled and refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California. |
| Long Name | IRIDEX Corporation |
| Market | us_market |
| Market Cap | 12,297,705 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_30288 |
| Most Recent Quarter | 1,783,123,200 |
| Net Income To Common | -3,547,000 |
| Next Fiscal Year End | 1,798,934,400 |
| Non Diluted Market Cap | 12,409,977 |
| Number Of Analyst Opinions | 1 |
| Open | 0.71 |
| Operating Cashflow | -1,730,000 |
| Operating Margins | -0.08189 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.94 |
| Phone | 650 940 4700 |
| Post Market Change | 0.0016999841 |
| Post Market Change Percent | 0.24062054 |
| Post Market Price | 0.7082 |
| Post Market Time | 1,787,958,316 |
| Previous Close | 0.7123 |
| Price Eps Current Year | -5.8875003 |
| Price Hint | 4 |
| Price To Book | -5.233333 |
| Price To Sales Trailing12 Months | 0.23845239 |
| Profit Margins | -0.06878 |
| Quick Ratio | 0.893 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.00580001 |
| Regular Market Change Percent | -0.814265 |
| Regular Market Day High | 0.7199 |
| Regular Market Day Low | 0.7001 |
| Regular Market Day Range | 0.7001 - 0.7199 |
| Regular Market Open | 0.71 |
| Regular Market Previous Close | 0.7123 |
| Regular Market Price | 0.7065 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 98,829 |
| Return On Assets | -0.05903 |
| Return On Equity | -0.73149 |
| Revenue Growth | -0.074 |
| Revenue Per Share | 2.991 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 17,406,518 |
| Shares Percent Shares Out | 0.0022 |
| Shares Short | 37,854 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 36,062 |
| Short Name | IRIDEX Corporation |
| Short Percent Of Float | 0.0034 |
| Short Ratio | 0.67 |
| Source Interval | 15 |
| State | CA |
| Symbol | IRIX |
| Target High Price | 2.75 |
| Target Low Price | 2.75 |
| Target Mean Price | 2.75 |
| Target Median Price | 2.75 |
| Total Cash | 4,680,000 |
| Total Cash Per Share | 0.266 |
| Total Debt | 4,013,000 |
| Total Revenue | 51,573,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.2 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.11355 |
| Two Hundred Day Average Change | -0.40704995 |
| Two Hundred Day Average Change Percent | -0.36554262 |
| Type Disp | Equity |
| Volume | 98,829 |
| Website | https://www.iridex.com |
| Zip | 94,043 |